97 related articles for article (PubMed ID: 7690310)
1. Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury.
Sawa H; Sobel BE; Fujii S
Circ Res; 1993 Oct; 73(4):671-80. PubMed ID: 7690310
[TBL] [Abstract][Full Text] [Related]
2. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis.
Sawa H; Lundgren C; Sobel BE; Fujii S
J Am Coll Cardiol; 1994 Dec; 24(7):1742-8. PubMed ID: 7963123
[TBL] [Abstract][Full Text] [Related]
3. A new butadiene derivative, T-686, inhibits plasminogen activator inhibitor type-1 production in vitro by cultured human vascular endothelial cells and development of atherosclerotic lesions in vivo in rabbits.
Vinogradsky B; Bell SP; Woodcock-Mitchell J; Ohtani A; Fujii S
Thromb Res; 1997 Feb; 85(4):305-14. PubMed ID: 9062954
[TBL] [Abstract][Full Text] [Related]
4. Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis.
Sawa H; Fujii S; Sobel BE
Arterioscler Thromb; 1992 Dec; 12(12):1507-15. PubMed ID: 1450183
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta.
Hamdan AD; Quist WC; Gagne JB; Feener EP
Circulation; 1996 Mar; 93(6):1073-8. PubMed ID: 8653825
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozil.
Fujii S; Sawa H; Sobel BE
Thromb Haemost; 1993 Oct; 70(4):642-7. PubMed ID: 7509512
[TBL] [Abstract][Full Text] [Related]
7. Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo.
Fujii S; Sawa H; Saffitz JE; Lucore CL; Sobel BE
Circulation; 1992 Dec; 86(6):2000-10. PubMed ID: 1451272
[TBL] [Abstract][Full Text] [Related]
8. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
Lundgren CH; Sawa H; Sobel BE; Fujii S
Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.
Shireman PK; McCarthy WJ; Pearce WH; Patterson BK; Shively VP; Cipollone M; Tamarina N; Verrusio EN; Kwaan HC
J Vasc Surg; 1996 May; 23(5):810-7; discussion 817-8. PubMed ID: 8667502
[TBL] [Abstract][Full Text] [Related]
11. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.
Lupu F; Bergonzelli GE; Heim DA; Cousin E; Genton CY; Bachmann F; Kruithof EK
Arterioscler Thromb; 1993 Jul; 13(7):1090-100. PubMed ID: 7686395
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of type-1 plasminogen activator inhibitor production by antisense oligonucleotides in human vascular endothelial and smooth muscle cells.
Sawa H; Sobel BE; Fujii S
J Biol Chem; 1994 May; 269(19):14149-52. PubMed ID: 8188696
[TBL] [Abstract][Full Text] [Related]
13. In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element.
Dichtl W; Ares MP; Stollenwerk M; Giachelli CM; Scatena M; Hamsten A; Eriksson P; Nilsson J
Thromb Haemost; 2000 Oct; 84(4):706-11. PubMed ID: 11057874
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.
Konstantinides S; Schäfer K; Thinnes T; Loskutoff DJ
Circulation; 2001 Jan; 103(4):576-83. PubMed ID: 11157725
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice.
Carmeliet P; Moons L; Lijnen R; Janssens S; Lupu F; Collen D; Gerard RD
Circulation; 1997 Nov; 96(9):3180-91. PubMed ID: 9386191
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
17. Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells.
Dichtl W; Stiko A; Eriksson P; Goncalves I; Calara F; Banfi C; Ares MP; Hamsten A; Nilsson J
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):3025-32. PubMed ID: 10591684
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.
Feener EP; Northrup JM; Aiello LP; King GL
J Clin Invest; 1995 Mar; 95(3):1353-62. PubMed ID: 7883982
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis.
Nordt TK; Klassen KJ; Schneider DJ; Sobel BE
Arterioscler Thromb; 1993 Dec; 13(12):1822-8. PubMed ID: 8241103
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1.
Redmond EM; Cullen JP; Cahill PA; Sitzmann JV; Stefansson S; Lawrence DA; Okada SS
Circulation; 2001 Jan; 103(4):597-603. PubMed ID: 11157728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
